Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.430
-0.090 (-3.57%)
Dec 3, 2024, 2:02 PM EST - Market open
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $171.83 million as of December 3, 2024. Its market cap has increased by 23.35% in one year.
Market Cap
171.83M
Enterprise Value
-85.60M
1-Year Change
23.35%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $171.83M, a decrease of -78.05%. That is a compound annual growth rate of -38.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 178.19M | 22.22% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KORU Medical Systems | 182.43M |
| Enanta Pharmaceuticals | 181.64M |
| Editas Medicine | 180.78M |
| Instil Bio | 179.98M |
| Inozyme Pharma | 179.23M |
| Galectin Therapeutics | 175.73M |
| The Joint | 175.61M |
| Actuate Therapeutics | 174.22M |